Announcement on Earnings Preannouncement for 2025
Filed with SSE · · 2 pages · Chinese
HeiLongJiang ZBD Pharmaceutical Co., Ltd. on 6ix
Earlier from HeiLongJiang ZBD Pharmaceutical
- Announcement on Pledge and Release of Pledge of Partial Shares of Controlling Shareholders
- Announcement on Resolutions of the 3rd Extraordinary General Meeting in 2025
- Announcement on Result of Shareholding Reduction by Shareholder with Over 5% Shares
- Announcement on Providing Additional Guarantee Amount for Wholly-owned Subsidiary
- Announcement on Obtaining Drug Registration Certificate by the Wholly-owned Subsidiary
Later from HeiLongJiang ZBD Pharmaceutical
- Announcement on Obtaining Notice of Approval for Marketing Application of Chemical APIs of Branch
- Announcement on Resignation of Chairman of the Board of Directors, Election of a New Chairman and Adjustment of Members of Special Committees of Board of Directors
- Indicative Announcement on Controlling Shareholder’s Proposed Supplementary Pledge of Shares for the Non-public Issuance of Exchangeable Corporate Bonds
- Notice on Convening the 1st Extraordinary General Meeting in 2026
- Indicative Announcement on Adjusting Conversion Price of Non-publicly Issued Exchangeable Corporate Bonds Held by Controlling Shareholders
Follow HeiLongJiang ZBD Pharmaceutical into a list and get an email when it puts out news.
Follow HeiLongJiang ZBD Pharmaceutical